The effects of live Saccharomyces cerevisiae (CNCM I-1077) supplementation to 72 Saanen dairy goats in early lactation were investigated. Animals were divided into treatment and control groups balanced for parity and milk production in the first 3 weeks of lactation. Treated animals received 0.2 g/day yeast supplement (Levucell SC20) corresponding to 4 × 109 cfu/day S. cerevisiae, beginning week 3 of lactation, and lasting 15 weeks. Dry matter intake (DMI), body condition score (BCS), milk production and composition were recorded to day126 postpartum. Milk samples were analysed weekly for fat, protein, lactose, urea and SCC. Blood samples were analysed monthly for glucose, BHBA, NEFA, GOT and GGT. Intestinal microflora were assessed monthly in faeces, assaying total bacteria, enterobacteria, E. coli, coliform bacteria, clostridia, lactobacilli, molds and yeast. BCS was not affected by the treatment, but treated animals had greater DMI (2.71 kg/day versus 2.35 kg/day, S.E. ±0.12, P < 0.001) and produced more (P < 0.05) milk (2.38 kg/day versus 2.08 kg/day, S.E. ±0.14) of lower fat content (P < 0.05). Plasma metabolites and liver enzymes (GOT, GGT) were similar between groups, although BHBA levels tended to be lower (P = 0.06) in treated animals. Faecal E. coli were reduced (0.72 log10 cfu/g versus 2.39 log10 cfu/g, S.E. ±0.38, P < 0.05) and lactobacilli increased (P < 0.05) by the treatment. Yeast faecal levels were higher (P < 0.001) in treated animals during supplementation. In this study, live yeast supplementation to early lactating dairy goats significantly increased milk production, in relation to increased DMI, without decreasing BCS. Plasma metabolites (glucose, BHBA and NEFA) were consistent with the BCS findings (no differences between groups) and in addition there was a significant reduction of faecal E. coli content together with increase in lactobacilli in the treated animals, suggesting greater stability of the intestinal ecosystem. Results suggest that the inclusion of Saccharomyces cerevisae in the diet of early lactating dairy goats can be recommended under field conditions.

Effect of administration of live Saccharomyces cerevisiae on milk production, milk composition, blood metabolites, and faecal flora in early lactating dairy goats / A.V. Stella, R. Paratte, L. Valnegri, G.L. Cigalino, G. Soncini, E. Chevaux, V. Dell’Orto, G. Savoini. - In: SMALL RUMINANT RESEARCH. - ISSN 0921-4488. - 67:1(2007 Jan), pp. 7-13.

Effect of administration of live Saccharomyces cerevisiae on milk production, milk composition, blood metabolites, and faecal flora in early lactating dairy goats

A.V. Stella
Primo
;
R. Paratte
Secondo
;
L. Valnegri;G.L. Cigalino;G. Soncini;V. Dell’Orto
Penultimo
;
G. Savoini
Ultimo
2007

Abstract

The effects of live Saccharomyces cerevisiae (CNCM I-1077) supplementation to 72 Saanen dairy goats in early lactation were investigated. Animals were divided into treatment and control groups balanced for parity and milk production in the first 3 weeks of lactation. Treated animals received 0.2 g/day yeast supplement (Levucell SC20) corresponding to 4 × 109 cfu/day S. cerevisiae, beginning week 3 of lactation, and lasting 15 weeks. Dry matter intake (DMI), body condition score (BCS), milk production and composition were recorded to day126 postpartum. Milk samples were analysed weekly for fat, protein, lactose, urea and SCC. Blood samples were analysed monthly for glucose, BHBA, NEFA, GOT and GGT. Intestinal microflora were assessed monthly in faeces, assaying total bacteria, enterobacteria, E. coli, coliform bacteria, clostridia, lactobacilli, molds and yeast. BCS was not affected by the treatment, but treated animals had greater DMI (2.71 kg/day versus 2.35 kg/day, S.E. ±0.12, P < 0.001) and produced more (P < 0.05) milk (2.38 kg/day versus 2.08 kg/day, S.E. ±0.14) of lower fat content (P < 0.05). Plasma metabolites and liver enzymes (GOT, GGT) were similar between groups, although BHBA levels tended to be lower (P = 0.06) in treated animals. Faecal E. coli were reduced (0.72 log10 cfu/g versus 2.39 log10 cfu/g, S.E. ±0.38, P < 0.05) and lactobacilli increased (P < 0.05) by the treatment. Yeast faecal levels were higher (P < 0.001) in treated animals during supplementation. In this study, live yeast supplementation to early lactating dairy goats significantly increased milk production, in relation to increased DMI, without decreasing BCS. Plasma metabolites (glucose, BHBA and NEFA) were consistent with the BCS findings (no differences between groups) and in addition there was a significant reduction of faecal E. coli content together with increase in lactobacilli in the treated animals, suggesting greater stability of the intestinal ecosystem. Results suggest that the inclusion of Saccharomyces cerevisae in the diet of early lactating dairy goats can be recommended under field conditions.
Dairy goat; Faecal flora; Milk; Saccharomyces cerevisae; Yeast
Settore VET/04 - Ispezione degli Alimenti di Origine Animale
Settore AGR/18 - Nutrizione e Alimentazione Animale
gen-2007
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/63856
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 131
  • ???jsp.display-item.citation.isi??? 107
social impact